No abstract available
Keywords:
cardiometabolic disorders; inflammation; neurological diseases; psychiatric disease; specialized proresolving lipid mediators.
Grants and funding
TS received a grant from FEDER funds via COMPETE, Portugal 2020—Operational Programme for Competitiveness and Internationalization (POCI) (POCI-01-0145-FEDER-032188) and from national funds through the Portuguese Foundation for Science and Technology (FCT) (RIFF-HEART project: PTDC/MEC-CAR/32188/2017). DP received a grant from Fundação Grünenthal Portugal. AR received grants from the Cystic Fibrosis Foundation (CFF US, Grant RECCHI20G1, RECCHI20G0) and the Fondazione per la Ricerca sulla Fibrosi Cistica (FFC)– Onlus (Grant FFC#20/2021). AR acknowledges the FFC local chapters of Naples, Treviso Montebelluna, and Acqui Terme for adopting the project. WAVJ receives Brazilian grants from PPSUS funded by Decit/SCTIE/MS intermediated by CNPq with support of Fundação Araucária and SESA-PR (agreement #041/2017); Programa de Apoio a Grupos de Excelência (PRONEX) grant supported by SETI/Fundação Araucária and MCTI/CNPq, and Governo do Estado do Paraná (agreement #014/2017); CNPq (#405027/2021-4; # 427946/2018-2; # 309633/2021-4) and Pesquisa Básica e Aplicada Grant supported by SETI/Fundação Araucária/UEL (#PBA2022011000098).